Andrew Moss
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Andrew Moss has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Alicia A. Boccellari
Department of Psychiatry, San Francisco General Hospital, CA 94110
1 shared publicationAlison Canchola
Centre for AIDS Prevention Studies, Department of Medicine, University of California San Francisco 74 New Montgomery, Ste 600, San Francisco, CA 94105
1 shared publicationAndrea Kim
Centre for AIDS Prevention Studies, Department of Medicine, University of California San Francisco 74 New Montgomery, Ste 600, San Francisco, CA 94105
1 shared publicationC. A. Liechty
Center for AIDS Prevention Studies, UCSF, California
1 shared publicationC. R. Kagay
University of California, San Francisco, School of Medicine, San Francisco, California 94110, USA
1 shared publicationCharles D. Yingling
1 shared publication
Latest Publications
- 1 August 2023
- Published by SAGE Publications in Adult Learning
- Vol. 34 (3) , 195-196
Book Review: The Community’s College: The Pursuit of Democracy, Economic Development, and Success
- 1 August 2023
- Published by SAGE Publications in Adult Learning
- Vol. 34 (3) , 195-196
Book Review: The Community’s College: The Pursuit of Democracy, Economic Development, and Success
- 1 July 2004
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 15 (7) , 479-483
HIV prevalence and risk factors among fishermen in Sihanouk Ville, Cambodia
We assessed HIV antibody and risk exposures in a cross-sectional sample of 446 fishermen in Sihanouk Ville, a port and fishing area in Cambodia, where high HIV prevalence has been found in sentinel surveillance studies. HIV prevalence was 16.1%, and was highest among unmarried men (17.3%) compared with married (14.6%). Men who stayed in port over one day had a significantly higher prevalence of HIV (31.7%) than those in port for ≤ day (14.6%). Men who had sex exclusively with their wife or girlfriend in the previous three months were significantly less likely to be HIV-infected than those who reported no sexual relations during the same time period (11% vs 23.7%, respectively). HIV infection in Cambodian fishermen was more than double that estimated in the general Khmer population. Although a large-scale condom promotion programme has been implemented in Sihanouk Ville, additional prevention programmes are needed to prevent further spread of HIV.
- 1 July 2004
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 15 (7) , 479-483
HIV prevalence and risk factors among fishermen in Sihanouk Ville, Cambodia
We assessed HIV antibody and risk exposures in a cross-sectional sample of 446 fishermen in Sihanouk Ville, a port and fishing area in Cambodia, where high HIV prevalence has been found in sentinel surveillance studies. HIV prevalence was 16.1%, and was highest among unmarried men (17.3%) compared with married (14.6%). Men who stayed in port over one day had a significantly higher prevalence of HIV (31.7%) than those in port for ≤ day (14.6%). Men who had sex exclusively with their wife or girlfriend in the previous three months were significantly less likely to be HIV-infected than those who reported no sexual relations during the same time period (11% vs 23.7%, respectively). HIV infection in Cambodian fishermen was more than double that estimated in the general Khmer population. Although a large-scale condom promotion programme has been implemented in Sihanouk Ville, additional prevention programmes are needed to prevent further spread of HIV.
- Open Access
- 1 June 2004
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 38 (Supplement) , S414-S420
Modeling the Impact of Modified Directly Observed Antiretroviral Therapy on HIV Suppression and Resistance, Disease Progression, and Death
A simulation model that used Markov assumptions with Monte Carlo uncertainty analysis was evaluated 1500 times at 10,000 iterations. Modified directly observed therapy (MDOT) for human immunodeficiency virus was assumed to improve adherence to therapy to 90% of prescribed doses. The impact of MDOT interventions on modeled biological and clinical outcomes was compared for populations with mean rates of adherence (i.e., the mean percentage of prescribed doses taken by each member of the population who had not discontinued therapy) of 40%, 50%, 60%, and 70%. MDOT reduced the risk of virological failure, development of opportunistic infections, and death, yet increased the risk of drug resistance, for each adherence distribution among persons with detectable plasma virus loads. Over 1500 trials, for a population with 50% adherence to therapy and a 12-month period, MDOT increased the median rate of virological suppression from 13.2% to 37.0% of patients, decreased the rate of opportunistic infection from 5.7% to 4.3% of patients, and decreased the death rate from 2.9% to 2.2% of patients. In the same population, however, MDOT increased the rate of new drug resistance mutations from 1.00 to 1.41 per person during the 12-month period. The impact of MDOT was smaller in populations with higher levels of adherence. MDOT interventions will likely improve clinical outcomes in populations with low levels of adherence but may not be effective at preventing drug resistance in treatment-experienced populations. MDOT may be more effective in preventing drug resistance with potent regimens in treatment-naive patients.
- 1 June 2004
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 38 (Supplement) , S414-S420
Open AccessModeling the Impact of Modified Directly Observed Antiretroviral Therapy on HIV Suppression and Resistance, Disease Progression, and Death
A simulation model that used Markov assumptions with Monte Carlo uncertainty analysis was evaluated 1500 times at 10,000 iterations. Modified directly observed therapy (MDOT) for human immunodeficiency virus was assumed to improve adherence to therapy to 90% of prescribed doses. The impact of MDOT interventions on modeled biological and clinical outcomes was compared for populations with mean rates of adherence (i.e., the mean percentage of prescribed doses taken by each member of the population who had not discontinued therapy) of 40%, 50%, 60%, and 70%. MDOT reduced the risk of virological failure, development of opportunistic infections, and death, yet increased the risk of drug resistance, for each adherence distribution among persons with detectable plasma virus loads. Over 1500 trials, for a population with 50% adherence to therapy and a 12-month period, MDOT increased the median rate of virological suppression from 13.2% to 37.0% of patients, decreased the rate of opportunistic infection from 5.7% to 4.3% of patients, and decreased the death rate from 2.9% to 2.2% of patients. In the same population, however, MDOT increased the rate of new drug resistance mutations from 1.00 to 1.41 per person during the 12-month period. The impact of MDOT was smaller in populations with higher levels of adherence. MDOT interventions will likely improve clinical outcomes in populations with low levels of adherence but may not be effective at preventing drug resistance in treatment-experienced populations. MDOT may be more effective in preventing drug resistance with potent regimens in treatment-naive patients.
- 1 May 1993
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 50 (5) , 517-521
Relationship of CD4 Counts to Neurophysiological Function in HIV-1-Infected Homosexual Men
• Objective. —To explore the relationship of immune dysfunction to neurophysiological measures of brain-stem conduction time. Design. —Three-year longitudinal prospective cohort study; results of time 1 analyses reported. Setting. —San Francisco (California) General Hospital, Departments of Psychiatry and Epidemiology. Patients. —Volunteer sample of 55 human immunodeficiency virus (HIV)-positive and 37 HIV-negative homosexual men recruited from a larger cohort of homosexual men followed up since 1983 at San Francisco General Hospital as part of an ongoing study of the natural history and course of HIV type 1 infection. Intervention. —None. Main Outcome Measures. —Auditory brain-stem responses and somatosensory evoked potentials for subjects stratified separately on HIV serostatus, Centers for Disease Control and Prevention symptom groupings, and absolute CD4 counts. Results. —The HIV-positive subjects had an increased wave III-V interpeak latency of the right ear auditory brain-stem response compared with the HIV-negative subjects (t test, P<.05). There were no significant differences among the three Centers for Disease Control and Prevention groupings on any evoked potential measure. When HIV-positive subjects were stratified on a measure of immune functioning, ie, CD4 counts, individuals with greater immune suppression were more impaired on speed of auditory brain-stem conduction time (Mann-Whitney U test, P<.05). Furthermore, 85% of subjects impaired on this evoked potential measure had CD4 counts of less than 0.40×109/L (400/μL), whereas only 15% of those impaired on this measure had CD4 counts of greater than 0.40×109/L. Conclusions. —Asymptomatic HIV-positive subjects who do not have evidence of immune suppression do not appear to be at greater risk for neurophysiological impairment than HIV-negative subjects. The HIV-positive individuals who are immune suppressed (even while asymptomatic) appear to have an increased likelihood of central conduction time slowing as measured by evoked potential procedures.
- 1 May 1993
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 50 (5) , 517-521
Relationship of CD4 Counts to Neurophysiological Function in HIV-1-Infected Homosexual Men
• Objective. —To explore the relationship of immune dysfunction to neurophysiological measures of brain-stem conduction time. Design. —Three-year longitudinal prospective cohort study; results of time 1 analyses reported. Setting. —San Francisco (California) General Hospital, Departments of Psychiatry and Epidemiology. Patients. —Volunteer sample of 55 human immunodeficiency virus (HIV)-positive and 37 HIV-negative homosexual men recruited from a larger cohort of homosexual men followed up since 1983 at San Francisco General Hospital as part of an ongoing study of the natural history and course of HIV type 1 infection. Intervention. —None. Main Outcome Measures. —Auditory brain-stem responses and somatosensory evoked potentials for subjects stratified separately on HIV serostatus, Centers for Disease Control and Prevention symptom groupings, and absolute CD4 counts. Results. —The HIV-positive subjects had an increased wave III-V interpeak latency of the right ear auditory brain-stem response compared with the HIV-negative subjects (t test, P<.05). There were no significant differences among the three Centers for Disease Control and Prevention groupings on any evoked potential measure. When HIV-positive subjects were stratified on a measure of immune functioning, ie, CD4 counts, individuals with greater immune suppression were more impaired on speed of auditory brain-stem conduction time (Mann-Whitney U test, P<.05). Furthermore, 85% of subjects impaired on this evoked potential measure had CD4 counts of less than 0.40×109/L (400/μL), whereas only 15% of those impaired on this measure had CD4 counts of greater than 0.40×109/L. Conclusions. —Asymptomatic HIV-positive subjects who do not have evidence of immune suppression do not appear to be at greater risk for neurophysiological impairment than HIV-negative subjects. The HIV-positive individuals who are immune suppressed (even while asymptomatic) appear to have an increased likelihood of central conduction time slowing as measured by evoked potential procedures.